On July 28, Unilever PLC rose 6.44% in pre-market trading, trading at 65.45 USD/share, with turnover of $306,800.

On the news front, the company released its first-half results showing performance that broadly exceeded market expectations, while simultaneously raising full-year sales growth guidance. Specifically, Unilever reported H1 adjusted EPS of $1.88, up 8.05% year-over-year from $1.74, with revenue reaching $29.902 billion. Underlying sales growth came in at 4.8% for the half, accelerating to 5.8% in Q2, led by particularly strong volume growth of 5.5%.

Additionally, the company upgraded its full-year outlook, now expecting underlying sales growth within its multi-year guidance range of 4% to 6%, with H2 growth of 4%-5% driven by pricing. The combination of above-consensus results and raised guidance reinforced market confidence in Unilever's growth momentum following its strategic focus on health and personal care businesses, propelling shares sharply higher in pre-market trading.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)